Cabometyx 40 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZB3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,467
Award facts
- Contract value 100% obligated
- $50,466.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $50,466.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count packages). This firm fixed-price delivery order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, was awarded without set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform this work at its headquarters location in Park Ridge, Illinois, serving the Defense Logistics Agency's Medical Supply Chain division as part of ongoing pharmaceutical supply operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $500 million ceiling and a completion date of December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group operates as one of multiple regional prime vendor contractors under this vehicle, with no identified subcontractors, positioning the company as a critical supplier within the federal pharmaceutical supply chain for military medical operations.
Quick answers
Who was awarded contract SPE2DR26FCZB3?
SPE2DR26FCZB3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FCZB3 worth?
The government has obligated $50,467 on SPE2DR26FCZB3.
Is contract SPE2DR26FCZB3 an order under another contract?
Yes. SPE2DR26FCZB3 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZB3 competed?
The extent of competition for SPE2DR26FCZB3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award